Cation-exchange recovery of scandium-44 for radiopharmaceutical purposes: post-processing of the 44Ti/44Sc generator eluate
Abstract Background. Scandium radionuclides ( 43 Sc, 44 Sc, and 47 Sc), owing to their favorable decay characteristics and coordination chemistry, attract attention in molecular imaging and targeted therapy, matching with clinically established 177 Lu and 90 Y, and forming element-matched theranostic pairs. However, clinical translation of accelerator-produced Sc radioisotopes or 44 Sc eluted from 44 Ti/ 44 Sc generators requires a final concentration and conditioning step to deliver Sc(III) in a minimal volume of biocompatible buffer for direct radiolabeling. In this study, nine commercial resins and six carboxylate buffers (30 conditions) were evaluated for single-step Sc(III) recovery enabling direct DOTA-conjugate labeling, using TEVA-based 44 Ti/ 44 Sc generator eluate (0.1 M H 2 C 2 O 4 / 0.2 M HCl) containing the competing ligand oxalate, and 0.1 M HCl as a model medium. Results. Static distribution coefficients ( D g ) and dynamic column profiles revealed that low-capacity silica-based cation-exchange resins were superior to high-capacity polymeric gels because high-yield desorption into 1 mL required a high eluent Na + / capacity ratio. Chromafix HR-XC sorbed 98.4 ± 1.1% of 44 Sc after fivefold generator eluate dilution with water; only Chromabond PSA sorbed 44 Sc quantitatively directly from the undiluted eluate (99.0 ± 0.5%). Across six pharmaceutically acceptable carboxylates (0.2–1.0 M, pH 4.00 ± 0.15), desorption and subsequent DOTA-labeling yields responded oppositely to a single thermodynamic variable: conditional availability of auxiliary Sc–carboxylate complexes, log( K 1 ·[L]) (Spearman ρ = −0.83). Among 30 conditions, 1 M sodium acetate was the global optimum (Y comb = Y des × RCY: 78.8 ± 1.7% vs. 72.1 ± 3.3% for 0.4 M succinate; p = 0.007). Acetate elution (1 mL) recovered 80.4 ± 2.7% (Chromabond PSA) and 79.4 ± 1.7% (Chromafix HR-XC). Residual oxalate was < 1.6 × 10 − 3 M. The conditioned solution enabled synthesis of [ 44 Sc]Sc-PSMA-617, [ 44 Sc]Sc-DOTA-TATE and [ 44 Sc]Sc-FAP-2286 (RCY 96.6–98.2%; 0.63–0.96 nmol precursor; apparent molar activities up to 50.0 ± 1.2 MBq/nmol). Conclusions. Two rapid (11–15 min) conditioning schemes provided 44 Sc for direct labeling at 4–5-fold higher volumetric activity than extraction chromatography. Established stoichiometric bed-capacity requirements, oxalate tolerance bounds and conditional auxiliary-ligand stability criteria may be transferable to the formulation and radiolabeling of 43 Sc, 44 Sc, and 47 Sc radiopharmaceuticals.
Authors
- А. А. Ларенков (ORCID: https://orcid.org/0000-0003-4810-4346)
- Павел Александрович Мирошин (ORCID: https://orcid.org/0009-0000-1120-9991)
Institutions
- State Scientific Center of the Russian Federation - Federal Medical Biophysical Center named after A.I. Burnazyan (RU)
- Federal Medical-Biological Agency (RU)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-11537752/v1
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- preprint